Spyre Therapeutics, Inc. (SYRE)

Last Closing Price: 15.55 (2025-05-29)

Earnings Announcements: Estimated vs Actual

On 2025-05-08, Spyre Therapeutics, Inc. (SYRE) announced earnings per share of $-0.74 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.76.

The next expected annoucement date for quarterly earnings is 2025-08-06, with an average estimated earnings per share of $-0.64 for the fiscal quarter ending 2025-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.

Announcement Date Fiscal Quarter End Estimated EPS Actual EPS
2025-05-08 2025-03-31 $-0.76 $-0.74
2025-02-27 2024-12-31 $-1.10 $-0.81
2024-11-07 2024-09-30 $-0.80 $-1.36
2024-08-07 2024-06-30 $-0.90 $-0.86
2024-05-09 2024-03-31 $-0.90 $-1.20
2024-02-29 2023-12-31 $-0.48 $-2.28
2023-11-09 2023-09-30 $-0.44 $-3.43
2023-08-11 2023-06-30 $-4.50 $-41.50
2023-05-11 2023-03-31 $-4.75 $-5.00
2023-03-02 2022-12-31 $-5.00 $-4.50
2022-11-03 2022-09-30 $-6.00 $-4.75
2022-08-04 2022-06-30 $-6.50 $-6.75
2022-05-05 2022-03-31 $-8.75 $-9.25
2022-03-08 2021-12-31 $-8.00 $-7.75
2021-11-04 2021-09-30 $-7.25 $-7.75
2021-08-05 2021-06-30 $-4.75 $-2.50
2021-05-10 2021-03-31 $-3.25 $-7.00
2021-03-18 2020-12-31 $-7.25 $-8.50
2020-11-05 2020-09-30 $-9.50 $-7.25
2020-08-10 2020-06-30 $-9.75 $-10.00
2020-05-07 2020-03-31 $-16.25 $-14.25
2020-02-24 2019-12-31 $-17.75 $-16.25
2019-11-06 2019-09-30 $-14.00 $-16.50
2019-08-06 2019-06-30 $-12.50 $-13.75
2019-05-07 2019-03-31 $-12.50 $-14.75
2019-03-07 2018-12-31 $-9.25 $-16.00
2018-11-08 2018-09-30 $-10.25 $-13.50
2018-08-09 2018-06-30 $-9.25 $-11.50
2018-05-08 2018-03-31 $-13.50 $-12.25
2018-03-13 2017-12-31 -- $-9.50
2017-11-07 2017-09-30 $-16.75 $-12.00
2017-08-09 2017-06-30 $-14.75 $-11.75
2017-05-09 2017-03-31 $-13.75 $-11.75
2017-03-23 2016-12-31 -- $-10.25
2016-11-09 2016-09-30 $-16.75 $-11.75
2016-08-09 2016-06-30 $-14.00 $-11.50
2016-05-19 2016-03-31 $-11.25 $-177.50